LUMI PRO Skin Booster (Single Syringe – 1 x 2ml)

LUMI-PRO

Injectable skin booster

Non-cross-linked hyaluronic acid skin booster for face, neck and hands

Marketed in the UK and EU as a professional Use non Cross Linked hyaluronic acid skin booster via regulated aesthetic wholesalers.
Manufactured under medical device and cosmetic injectable quality systems (e.g. ISO 13485) as applicable for HA Based injectable devices; exact CE/UKCA marking and device classification should be confirmed from packaging and technical documentation.
Intended only for administration by appropriately trained medical/aesthetic professionals in compliance with national regulations governing injectable hyaluronic acid skin boosters.

Marketed in the UK and EU as a professional Use non Cross Linked hyaluronic acid skin booster via regulated aesthetic wholesalers.
Manufactured under medical device and cosmetic injectable quality systems (e.g. ISO 13485) as applicable for HA Based injectable devices; exact CE/UKCA marking and device classification should be confirmed from packaging and technical documentation.
Intended only for administration by appropriately trained medical/aesthetic professionals in compliance with national regulations governing injectable hyaluronic acid skin boosters.

Non-cross-linked hyaluronic acid skin booster for face, neck and hands

Description

LUMI-PRO Skin Booster (Single Syringe – 1 x 2ml) is a state-of-the-art injectable moisturiser designed to deliver intense, long-lasting hydration and visible radiance to the skin. Each single-use 2 ml syringe contains a market-leading 40 mg of ultra-pure, non-cross-linked hyaluronic acid (HA), giving it one of the highest HA concentrations among skin boosters. Developed by UK Skin-Tech Innovation and manufactured by BNC Korea, LUMI-PRO is intended for use on the face, neck and hands. It works by restoring and maintaining deep dermal hydration, stimulating collagen production and improving elasticity, resulting in smoother, firmer and more luminous skin. Unlike traditional volumising fillers, LUMI-PRO focuses on skin quality and glow, making it ideal as a stand-alone regenerative treatment or as a complement to other aesthetic procedures.

Bnefits

Delivers intense, deep-layer skin hydration with 40 mg of non-cross-linked hyaluronic acid in a 2 ml syringe.
Promotes collagen stimulation and improved dermal firmness and elasticity.
Provides a natural, effortless glow and fresher, more youthful-looking skin.
Helps smooth fine lines and early wrinkles by plumping and hydrating the dermis.
Highly versatile: suitable for full face, neck and hands for total skin quality improvement.
Higher HA content than many leading skin booster brands, offering strong hydrating power and value per ml.
Visible results often reported within as little as 48 hours after treatment.
Non-volumising formulation targets hydration and skin health rather than structural contouring.
Smooth application characteristics designed to integrate evenly for a natural finish.
Can be combined with other injectable or device-based treatments as part of a comprehensive rejuvenation plan.

Indications

Dehydrated, dull or tired-looking skin on the face, neck and hands.
Fine lines and superficial wrinkles associated with photoageing and loss of dermal hydration.
Loss of skin elasticity and firmness where improved turgor and resilience are desired.
Uneven skin texture or roughness requiring improvement in smoothness and suppleness.
Patients seeking a non-surgical, non-volumising treatment focused on glow and skin quality rather than contour change.
Supportive treatment for skin recovery and hydration after other aesthetic procedures, where appropriate and timed correctly.
Suitable for a wide range of adult patients with early to moderate signs of ageing or dryness, at the practitioner’s discretion.

Composition

Non-cross-linked hyaluronic acid (HA) 40 mg per 2 ml syringe (20 mg/ml).
Sterile aqueous carrier (water for injection).
Sodium chloride and buffer salts (e.g. phosphate buffers) to maintain physiological pH and osmolality.
Trace stabilisers and excipients as declared in the manufacturer’s internal formulation and Instructions for Use.
No lidocaine listed in publicly available product information; analgesia is typically provided separately according to clinic protocol.

Formulation

Sterile, clear, non-cross-linked hyaluronic acid solution for intradermal/subdermal injection.
HA concentration: 40 mg in 2 ml (20 mg/ml) aimed at hydrating and revitalising the skin without significant structural volumising.
Skin-booster rheology formulated to spread evenly in the dermis, providing smooth application and integration.
Intended for multiple injection points within a single treatment session for one patient.

Packaging

Single pack containing 1 x 2 ml pre-filled sterile syringe of LUMI-PRO Skin Booster.
Syringe presented in a protective blister tray within a branded outer carton marked "1 x 2 ml | 40 mg HA Treatment".
Packaging includes product name, HA content (40 mg/2 ml), batch/lot number, expiry date, storage instructions and manufacturer/distributor details.
Designed as a premium single-pack presentation for professional clinic use; syringe is single-use and must not be reused or shared.

Usage

For professional use only; to be administered by qualified healthcare or aesthetic practitioners familiar with skin booster techniques and facial anatomy.
Indicated areas include face, neck and hands; injection depth is typically superficial to mid-dermis depending on area and technique.
Before treatment, perform a full medical history, skin assessment and obtain informed consent; identify primary concerns such as dehydration, fine lines or loss of glow.
Cleanse and disinfect the treatment area; apply topical anaesthetic if required and in line with clinic protocol.
Use a fine-gauge needle (e.g. 30G) or suitable mesotherapy device; inject small aliquots using micro-droplet, serial puncture, linear threading or nappage techniques, distributing the product evenly across the treatment zone.
Avoid intravascular injection by respecting anatomical danger zones, injecting slowly and applying aspiration where appropriate per clinic policy.
A typical protocol may involve 1–3 treatment sessions spaced around 3–4 weeks apart, with maintenance sessions every 6–12 months depending on skin condition and patient goals.
After treatment, advise patients to avoid makeup on treated areas for at least 12–24 hours and to refrain from strenuous exercise, alcohol, saunas/steam rooms and intense heat or sun exposure for 24–48 hours.
Recommend daily use of a broad-spectrum sunscreen and appropriate skincare to support and prolong results.
Document the treatment, including injection sites, total volume used and any immediate reactions, and schedule follow-up to assess outcome.

Contraindications

Known hypersensitivity or allergy to hyaluronic acid or any of the excipients in the formulation.
History of severe allergic reactions or anaphylaxis to injectable HA products.
Active skin infection, inflammation or disease (e.g. bacterial, viral such as herpes simplex, or fungal) at or near the intended injection sites.
Uncontrolled systemic illness, autoimmune disease, significant immunosuppression or coagulation disorders, unless thoroughly evaluated and cleared by a medical professional.
Pregnancy and breastfeeding, as elective cosmetic injectables are generally avoided due to limited safety data.
Recent laser, deep chemical peel or other aggressive procedures in the same area without adequate healing time.
Presence of permanent fillers, implants or foreign bodies in the treatment zone requiring special caution and expert assessment.
Any additional contraindications and warnings specified in the manufacturer’s professional Instructions for Use and in local clinical guidelines for injectable HA skin boosters.

Adverse Effects

Common, mild and transient injection-site reactions: redness, tenderness, swelling, bruising, small haematomas, itching or warmth.
Temporary papules or small lumps at injection points which typically resolve within days as the product disperses.
Occasional asymmetry or unevenness immediately after treatment due to swelling or localised product deposition, usually improving as oedema subsides.
Less common reactions include prolonged swelling, local inflammatory responses or nodules that may require clinical management.
Rare hypersensitivity or allergic-type reactions to hyaluronic acid or excipients, presenting with persistent erythema, oedema or pruritus.
Very rare but serious complications include vascular occlusion from inadvertent intravascular injection; practitioners must be trained to recognise symptoms such as sudden severe pain, blanching, mottling or tissue discolouration and initiate emergency management per protocol.
Risk of infection at injection sites if aseptic technique is not followed, potentially requiring antibiotic treatment.
Patients should be advised to seek prompt medical attention if they experience severe pain, spreading redness, significant or worsening swelling, skin discolouration, ulceration or systemic symptoms.

Storage Conditions

Store in the original outer carton in a cool, dry place away from direct sunlight and heat sources.
Maintain at the temperature range indicated on the packaging (typically between 2°C and 25°C); do not freeze.
Do not use if the packaging, blister or syringe is damaged, opened or shows signs of tampering.
Inspect visually before use; do not inject if the solution appears cloudy, discoloured or contains particulate matter.
Do not use after the expiry date printed on the carton and syringe.
Store out of the reach of children and unauthorised persons, in accordance with local regulations for injectable medical-aesthetic products.

Duration

Hydration and glow are typically noticeable within days, with optimal improvement emerging over several weeks as dermal hydration equilibrates and collagen stimulation takes effect. Results commonly persist for several months after a course of treatment. Many practitioners adopt protocols of 1\u20133 initial sessions followed by maintenance treatments approximately every 6\u201312 months, adjusted to patient age, skin condition and lifestyle.

Onset

According to brand and clinic descriptions, initial visible benefits such as increased hydration and glow may appear within 24\u201348 hours after treatment, with further improvements in texture, fine lines and firmness developing gradually over the following weeks as hyaluronic acid integrates and collagen activity increases.